User:Harish Srinivas: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 62: | Line 62: | ||
[[Image:Nervous system'.jpg]] | [[Image:Nervous system'.jpg]] | ||
References | |||
1.An update on the biology of sphingosine 1-phosphate receptors | |||
Victoria A. Blaho and Timothy Hla* | |||
Center for Vascular Biology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, 1300 York Ave., New York, NY 10065 | |||
2.Lipid Receptor S1P1 Activation Scheme Concluded from Microsecond All-Atom Molecular Dynamics Simulations | |||
Shuguang Yuan1,2,3*, Rongliang Wu1, Dorota Latek1, Bartosz Trzaskowski4, Slawomir Filipek4* | |||
1International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland, 2Laboratory of Physical Chemistry of Polymers and Membranes, E ´cole Polytechnique Fe ´de ´rale de Lausanne, SB ISIC LCPPM, Lausanne, Switzerland, 3Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland, 4Faculty of Chemistry, University of Warsaw, Warsaw, Poland | |||
3.Sphingosine-1-phosphate metabolism: A structural perspective | |||
Michael J. Pulkoski-Gross1, Jane C. Donaldson2,3, and Lina M. Obeid2,3,4 1Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA | |||
2Department of Medicine, Stony Brook University, Stony Brook, NY, USA | |||
3Stony Brook Cancer Center, Stony Brook, NY, USA | |||
4Northport Veterans Affairs Medical Center, Northport, NY, USA | |||
4.Structural Biology of the S1P1 Receptor | |||
Michael A. Hanson and Robert Peach | |||
5.Structure of the First Sphingosine 1-Phosphate Receptor | |||
Abby L. Parrill1,*, Santiago Lima2, and Sarah Spiegel2,* 1Department of Chemistry, The University of Memphis, 213 Smith Chemistry Building, Memphis, TN 38152, USA 2Department of Biochemistry and Molecular Biology, Virginia Commonwealth University (VCU) School of Medicine, 1101 East Marshall Street, Richmond, VA 23298, USA | |||
6.A Single Amino Acid Determines Lysophospholipid Specificity of the S1P1 (EDG1) and LPA1 (EDG2) Phospholipid Growth Factor Receptors* | |||
Received for publication, July 31, 2001, and in revised form, October 15, 2001 Published, JBC Papers in Press, October 16, 2001, DOI 10.1074/jbc.M107301200 | |||
De-an Wang‡§, Zsolt Lorincz‡§, Debra L. Bautista¶�, Karoly Liliom‡**, Gabor Tigyi‡ ‡‡, and Abby L. Parrill¶‡‡§§ From the ‡Department of Physiology, University of Tennessee Health Sciences Center Memphis, Memphis, Tennessee 38163 and the ¶Department of Chemistry and Computational Research on Materials Institute, The University of Memphis, Memphis, Tennessee 38152 | |||
7.Defective sphingosine-1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation | |||
Christopher S. Garris1,2,*, Linfeng Wu3,*, Swati Acharya4, Ahmet Arac5, Victoria A. Blaho6, Yingxiang Huang1, Byoung San Moon1, Robert C. Axtell1, Peggy P. Ho1, Gary K. Steinberg5, David B. Lewis4, Raymond A. Sobel7, David K. Han8, Lawrence Steinman1, Michael P. Snyder3, Timothy Hla6, and May H. Han1 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA | |||
2Graduate Program in Immunology, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA | |||
3Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA | |||
4Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Stanford, CA 94305, USA | |||
5Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA | |||
6Center for Vascular Biology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA | |||
7Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA | |||
8Center for Vascular Biology, Department of Cell Biology, University of Connecticut Health Center, Farmington, CT 06030, USA | |||
8.Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design Hai-Yun Xiao,† Scott H. Watterson,† Charles M. Langevine,† Anurag S. Srivastava,† Soo S. Ko,† Yanlei Zhang,† Robert J. Cherney,† Wei-Wei Guo,† John L. Gilmore,† James E. Sheppeck, II,† Dauh-Rurng Wu,† Peng Li,† Duraisamy Ramasamy,‡ Piramanayagam Arunachalam,‡ Arvind Mathur,† Tracy L. Taylor,† David J. Shuster,† Kim W. McIntyre,† Ding-Ren Shen,† Melissa Yarde,† Mary Ellen Cvijic,† Anthony M. Marino,† Praveen V. Balimane,† Zheng Yang,† Dana M. Banas,† Georgia Cornelius,† Celia J. D’Arienzo,† Bethanne M. Warrack,† Lois Lehman-McKeeman,† Luisa M. Salter-Cid,† Jenny Xie,† Joel C. Barrish,† Percy H. Carter,† Alaric J. Dyckman,† and T. G. Murali Dhar*,† †Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States ‡BMS Biocon Research Center, Bangalore 560099, India | |||
9.S1P1-Selective In Vivo-Active Agonists from HighThroughput Screening: Off-the-Shelf Chemical Probes of Receptor Interactions, Signaling, and Fate | |||
Euijung Jo,1 M. Germana Sanna,1, Pedro J. Gonzalez-Cabrera, 1 Shobha Thangada,2, Gabor Tigyi,3 Daniel A. Osborne,4 Timothy Hla,2, Abby L. Parrill, 4 and Hugh Rosen1,*, 1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, ICND 118La Jolla, California 92037 2Center for Vascular Biology, University of Connecticut Health Center, Farmington, Connecticut 06030 3Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, 4Department of Chemistry, University of Memphis, Memphis, Tennessee 38152 | |||
10.Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors Michael J Bradaric1, Animesh Barua1,2,3, Krishna Penumatsa1, Yu Yi 1, Seby L Edassery1, Sameer Sharma2,4, Jacques S Abramowicz2, Janice M Bahr5, Judith L Luborsky1,2* | |||
